Contact Us

SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D.
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
Oct 13, 2009	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	View HTML 0001209191-09-048456.pdf 0001209191-09-048456.rtf
Oct 23, 2009	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Proxy Filings	View HTML 0001193125-09-212757.pdf 0001193125-09-212757.rtf 0001193125-09-212757.xls
Nov 05, 2009	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001193125-09-225602.pdf 0001193125-09-225602.rtf 0001193125-09-225602.xls
Nov 06, 2009	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	View HTML 0001193125-09-226876.pdf 0001193125-09-226876.rtf 0001193125-09-226876.xls
Nov 10, 2009	S-1/A	Amended Registration statement for face-amount certificate companies	Registration Statements	View HTML 0001193125-09-230879.pdf 0001193125-09-230879.rtf 0001193125-09-230879.xls
Nov 10, 2009	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001193125-09-230637.pdf 0001193125-09-230637.rtf 0001193125-09-230637.xls
Nov 10, 2009	ARS	An annual report to security holders	Annual Filings	View HTML
Nov 13, 2009	EFFECT	EFFECT	Other	View HTML 9999999995-09-003183.pdf 9999999995-09-003183.rtf
Nov 13, 2009	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-09-000021.pdf 0001232524-09-000021.rtf
Nov 17, 2009	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0001232524-09-000022.pdf 0001232524-09-000022.rtf

Data provided by Kaleidoscope.